These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 37602155)
1. Co occurrance of Macular Telangiectasia type 2 with hemorrhagic polypoidal choroidal vasculopathy and response to anti-vascular endothelial growth factor. Shah S; Manayath GJ; Gajula S; Narendran V Oman J Ophthalmol; 2023; 16(2):342-346. PubMed ID: 37602155 [TBL] [Abstract][Full Text] [Related]
2. A case of bilateral pachychoroid disease: polypoidal choroidal vasculopathy in one eye and peripheral exudative hemorrhagic chorioretinopathy in contralateral eye. Kitagawa Y; Shimada H; Kawamura A; Tanaka K; Mori R; Onoe H; Nakashizuka H BMC Ophthalmol; 2021 Sep; 21(1):320. PubMed ID: 34481477 [TBL] [Abstract][Full Text] [Related]
3. IMPROVED DETECTION AND DIAGNOSIS OF POLYPOIDAL CHOROIDAL VASCULOPATHY USING A COMBINATION OF OPTICAL COHERENCE TOMOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Cheung CMG; Yanagi Y; Akiba M; Tan A; Mathur R; Chan CM; Yeo I; Wong TY Retina; 2019 Sep; 39(9):1655-1663. PubMed ID: 29927796 [TBL] [Abstract][Full Text] [Related]
4. Macular telangiectasia type II with pachychoroid spectrum of macular disorders. Kumar V; Kumar P; Ravani R; Gupta P Eur J Ophthalmol; 2019 Mar; 29(2):216-222. PubMed ID: 29676172 [TBL] [Abstract][Full Text] [Related]
5. Differentiating Exudative Macular Degeneration and Polypoidal Choroidal Vasculopathy Using OCT B-Scan. Kokame GT; Omizo JN; Kokame KA; Yamane ML Ophthalmol Retina; 2021 Oct; 5(10):954-961. PubMed ID: 34022443 [TBL] [Abstract][Full Text] [Related]
6. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results. Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105 [TBL] [Abstract][Full Text] [Related]
7. Polypoidal choroidal vasculopathy in a case with retinitis pigmentosa. Ishida T; Moriyama M; Morohoshi K; Furuse Y; Fukuda T; Ohno-Matsui K Int Ophthalmol; 2013 Jun; 33(3):305-8. PubMed ID: 23132213 [TBL] [Abstract][Full Text] [Related]
8. THE INCIDENCE, CHARACTERISTICS, MANAGEMENT, PROGNOSIS, AND CLASSIFICATION OF BREAKTHROUGH VITREOUS HEMORRHAGE SECONDARY TO POLYPOIDAL CHOROIDAL VASCULOPATHY. Zhao XY; Luo MY; Meng LH; Zhang WF; Li B; Wang EQ; Liu SZ; Yu WH; Chen YX Retina; 2021 Aug; 41(8):1675-1685. PubMed ID: 33395221 [TBL] [Abstract][Full Text] [Related]
9. Peripheral polypoidal choroidal vasculopathy as a cause of peripheral exudative hemorrhagic chorioretinopathy: a report of 10 eyes. Goldman DR; Freund KB; McCannel CA; Sarraf D Retina; 2013 Jan; 33(1):48-55. PubMed ID: 22836900 [TBL] [Abstract][Full Text] [Related]
10. Current management strategy of polypoidal choroidal vasculopathy. Ho CPS; Lai TYY Indian J Ophthalmol; 2018 Dec; 66(12):1727-1735. PubMed ID: 30451173 [TBL] [Abstract][Full Text] [Related]
11. Atypical case of perifoveal exudative vascular anomalous complex associated with pachychoroid pigment epitheliopathy. Herda N; Semoun O; Srour M; Amoroso F; Baker M; Capuano V; Colantuono D; Cohen SY; Querques G; Souied EH Am J Ophthalmol Case Rep; 2022 Dec; 28():101691. PubMed ID: 36090303 [TBL] [Abstract][Full Text] [Related]
13. EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY. Dansingani KK; Balaratnasingam C; Naysan J; Freund KB Retina; 2016 Mar; 36(3):499-516. PubMed ID: 26335436 [TBL] [Abstract][Full Text] [Related]
14. Using optical coherence tomography angiography in assessment of the anti-vascular endothelial growth factor effect for pathological vascular tissue in age-related macular degeneration and polypoidal choroidal vasculopathy. Shen YS; Cheng CK Eur J Ophthalmol; 2021 May; 31(3):1267-1280. PubMed ID: 32228025 [TBL] [Abstract][Full Text] [Related]
15. Polypoidal choroidal vasculopathy: natural history. Uyama M; Wada M; Nagai Y; Matsubara T; Matsunaga H; Fukushima I; Takahashi K; Matsumura M Am J Ophthalmol; 2002 May; 133(5):639-48. PubMed ID: 11992861 [TBL] [Abstract][Full Text] [Related]
16. The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and proposal of a classification. van Dijk EHC; Mohabati D; Veselinovic S; Chung WH; Dijkman G; Boon CJF Graefes Arch Clin Exp Ophthalmol; 2021 Feb; 259(2):351-361. PubMed ID: 32812132 [TBL] [Abstract][Full Text] [Related]
17. Prevalence and Risk Factors for Nonexudative Neovascularization in Fellow Eyes of Patients With Unilateral Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy. Yanagi Y; Mohla A; Lee WK; Lee SY; Mathur R; Chan CM; Yeo I; Wong TY; Cheung CMG Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3488-3495. PubMed ID: 28702676 [TBL] [Abstract][Full Text] [Related]
18. POLYPOIDAL CHOROIDAL VASCULOPATHY ASSOCIATED WITH CENTRAL SEROUS CHORIORETINOPATHY: Pachychoroid Spectrum of Diseases. Manayath GJ; Shah VS; Saravanan VR; Narendran V Retina; 2018 Jun; 38(6):1195-1204. PubMed ID: 28445211 [TBL] [Abstract][Full Text] [Related]
19. Polypoidal choroidal vasculopathy - a type I polypoidal subretinal neovasculopathy. Kokame GT Open Ophthalmol J; 2013; 7():82-4. PubMed ID: 24265653 [TBL] [Abstract][Full Text] [Related]